Novo Nordisk and Eli Lilly have used submissions to the federal government’s budget process to argue reducing obesity will be ...

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and ...

Novo Nordisk's anti-TFPI antibody concizumab has ... Alhemo – is already approved in other markets, including Japan, Australia, and Switzerland, but was rejected by the FDA last year with ...

Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine. The lawsuit, filed ...

Novo Nordisk, a pharmaceutical group from Denmark, plans to utilize its 500 out of 3000 strong personnel on sales in the United States to market its "new obesity drugs," Jakob Riis, Executive Vice ...